eCite Digital Repository

Eezer Goode? Subjective experiences of emerging psychoactive substances

Citation

Matthews, AJ and Bruno, RB, Eezer Goode? Subjective experiences of emerging psychoactive substances, Drug and Alcohol Review, 18-21 November 2012, Melbourne, Victoria, pp. 51. ISSN 0959-5236 (2012) [Conference Extract]


Preview
PDF
Pending copyright assessment - Request a copy
615Kb
  

Abstract

Issue: Emerging psychoactive substances (EPS) are relatively new substances that have not been formally studied or are still being researched. As such, little is known about the effects and risks of using these drugs and there have been few animal or human toxicology studies examining issues such as acute adverse events, drug interactions, long-term health impacts or addiction. Data from the Ecstasy and Related Drugs Reporting System, an annual national Australian drug market monitoring system, has indicated increased use of EPS substances among regular ecstasy using cohorts in recent years. The EPS most commonly used by these participants include psychedelic phenethylamines (2CI, 2CB, 2CE) and the stimulants 4-methylmethcathinone (mephedrone) and methylone (bk-MDMA). Approach: Participants interviewed in the 2012 Ecstasy and Related Drugs Reporting System were asked to provide subjective ratings on the EPS that they had used in the last six months. Participants rated the pleasurable effects and the negative effects (both acute and longer-term) of each drug on the last occasion of use and also rated the likelihood that they would use the drug again. Key Findings: Ratings in relation to EPS were compared to those of more commonly used drugs such as ecstasy, cocaine and LSD revealing interesting similarities and differences in subjective profi les. Implications: These fi ndings have important implications for understanding the use and abuse potential for emerging substances in the psychostimulant drug market. Conclusion: Given the substantially greater dependence potential of some substances (e.g. cocaine and mephedrone) in comparison to ecstasy, careful monitoring of consumption changes in these demographics is warranted.

Item Details

Item Type:Conference Extract
Keywords:drug
Research Division:Psychology and Cognitive Sciences
Research Group:Psychology
Research Field:Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)
Objective Division:Health
Objective Group:Public Health (excl. Specific Population Health)
Objective Field:Substance Abuse
Author:Matthews, AJ (Dr Allison Matthews)
Author:Bruno, RB (Associate Professor Raimondo Bruno)
ID Code:83695
Year Published:2012
Deposited By:Psychology
Deposited On:2013-03-20
Last Modified:2013-03-20
Downloads:1 View Download Statistics

Repository Staff Only: item control page